trending Market Intelligence /marketintelligence/en/news-insights/trending/cjY6ZLCof98vCUF8DjxjMQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Gilead promotes executive to replace outgoing CFO

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Gilead promotes executive to replace outgoing CFO

Gilead Sciences Inc. named Andrew Dickinson its new CFO, replacing Robin Washington, effective Nov. 1.

Dickinson has been with the company since 2016 and is executive vice president, corporate development and strategy. He will continue with the role after he becomes CFO, Gilead said in an Oct. 15 release.

The executive led Gilead's 2017 acquisition of Kite Pharma Inc., and the $5.05 billion research collaboration with Galapagos NV that was announced in July, the company said. Dickinson served as global co-head of healthcare investment banking at Lazard Frères & Co. before joining Gilead.

Washington will remain with the company in an advisory capacity until early 2020 and will work with Dickinson during the transition.